131 results
Page 5 of 7
8-K
EX-99.1
izoccj0tyn7tiiyc
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.2
pz8w4j2 h83o5aro
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
thrwer3v35lclcu
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm
8-K
EX-99.1
478umw12mys
13 Jan 20
Results of Operations and Financial Condition
5:11pm
S-3ASR
ik39 6suxugwvo
18 Nov 19
Automatic shelf registration
5:18pm
8-K
EX-99.1
ggx6 c2ie
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
EX-99.1
z94 si4lgxzv2r
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
S-3ASR
2c7oh9
8 Aug 19
Automatic shelf registration
6:25am
S-3ASR
7bzectin58eybg8x
8 Aug 19
Automatic shelf registration
6:15am
8-K
EX-99.1
zfsh3ve m4tf1li
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm
8-K
EX-99.1
2thn4gnja1672 ogr
11 Jul 19
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-99.1
ekv8bp802m
17 Jun 19
Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy
8:41am
8-K
EX-99.1
h1ju0dk6ts90c5o
7 May 19
Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year
4:15pm
8-K
EX-99.1
w8u 6tzgz2mqmck
6 Mar 19
Invitae Announces Pricing of Public Offering of Common Stock
4:54pm
424B5
bnlm8l41jurae1 d1
6 Mar 19
Prospectus supplement for primary offering
4:14pm